| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |